THAIS KREIDER: Open Payments
NPI 1154960326 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,355 in 51 payments from 14 companies in 2025. Trend: 2023 $1,954 · 2024 $1,872 · 2025 $1,355
Food & beverage: $1,355
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $249 |
| Abbott Laboratories | 20 | $247 |
| ABBVIE INC. | 12 | $187 |
| Novo Nordisk Inc | 4 | $135 |
| AstraZeneca Pharmaceuticals LP | 2 | $133 |
| Eisai Inc. | 1 | $123 |
| MDD US Operations, LLC | 1 | $118 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: FREESTYLE LIBRE 3, VRAYLAR, Leqembi, FARXIGA, Wegovy, LEQVIO, UBRELVY, JARDIANCE.
Industry payments across FL — which companies pay providers there.
